Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 19

1.

The comparative effects of telmisartan and ramipril on P-wave dispersion in hypertensive patients: a randomized clinical study.

Celik T, Iyisoy A, Kursaklioglu H, Yilmaz MI, Kose S, Kilic S, Amasyali B, Demirkol S, Isik E.

Clin Cardiol. 2005 Jun;28(6):298-302.

PMID:
16028466
[PubMed - indexed for MEDLINE]
2.

Telmisartan versus angiotension-converting enzyme inhibitors in the treatment of hypertension: a meta-analysis of randomized controlled trials.

Zou Z, Xi GL, Yuan HB, Zhu QF, Shi XY.

J Hum Hypertens. 2009 May;23(5):339-49. doi: 10.1038/jhh.2008.132. Epub 2008 Nov 6. Review.

PMID:
18987649
[PubMed - indexed for MEDLINE]
3.

The ongoing telmisartan alone and in combination with ramipril global endpoint trial program.

Unger T.

Am J Cardiol. 2003 May 22;91(10A):28G-34G. Review.

PMID:
12781906
[PubMed - indexed for MEDLINE]
4.

Achieving blood pressure goals: should angiotensin II receptor blockers become first-line treatment in hypertension?

Weber M.

J Hypertens Suppl. 2009 Jul;27(5):S9-14. doi: 10.1097/01.hjh.0000357903.93951.73. Review.

PMID:
19587555
[PubMed - indexed for MEDLINE]
5.

Telmisartan prevents cardiovascular events in a broad group of at-risk patients.

Baumhäkel M, Böhm M.

Expert Opin Pharmacother. 2009 Dec;10(18):3113-7. doi: 10.1517/14656560903449231. Review.

PMID:
19925045
[PubMed - indexed for MEDLINE]
6.

Telmisartan in high-risk cardiovascular patients.

Weber MA.

Am J Cardiol. 2010 Jan 4;105(1 Suppl):36A-43A. doi: 10.1016/j.amjcard.2009.10.008. Review.

PMID:
20102972
[PubMed - indexed for MEDLINE]
7.

New standards in hypertension and cardiovascular risk management: focus on telmisartan.

Galzerano D, Capogrosso C, Di Michele S, Galzerano A, Paparello P, Lama D, Gaudio C.

Vasc Health Risk Manag. 2010 Mar 24;6:113-33. Review.

PMID:
20448797
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Preventing stroke: the PRoFESS, ONTARGET, and TRANSCEND trial programs.

Diener HC.

J Hypertens Suppl. 2009 Jul;27(5):S31-6. doi: 10.1097/01.hjh.0000357906.60778.7f. Review.

PMID:
19587553
[PubMed - indexed for MEDLINE]
9.

Clinical effectiveness of telmisartan alone or in combination therapy for controlling blood pressure and vascular risk in the elderly.

Jugdutt BI.

Clin Interv Aging. 2010 Dec 3;5:403-16. doi: 10.2147/CIA.S6709. Review.

PMID:
21152242
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Lessons learned from the ONTARGET and TRANSCEND trials.

Basile J.

Curr Atheroscler Rep. 2009 Sep;11(5):371-6. Review.

PMID:
19664381
[PubMed - indexed for MEDLINE]
11.

Pre-clinical and clinical experience of telmisartan in cardiac remodelling.

Verdecchia P.

J Int Med Res. 2005;33 Suppl 1:12A-20A. Review.

PMID:
16222896
[PubMed - indexed for MEDLINE]
12.

Rationale for double renin-angiotensin-aldosterone system blockade.

Unger T, Stoppelhaar M.

Am J Cardiol. 2007 Aug 6;100(3A):25J-31J. Epub 2007 May 25. Review.

PMID:
17666194
[PubMed - indexed for MEDLINE]
13.

[Renin-angiotensin-aldosterone system inhibition and cardiovascular protection].

Oğuz A.

Turk Kardiyol Dern Ars. 2009 Oct;37 Suppl 6:4-12. Review. Turkish.

PMID:
20019467
[PubMed - indexed for MEDLINE]
14.

Recent advances in cardiovascular risk reduction: implications of ONTARGET.

Guthrie R.

Clin Cornerstone. 2009;9 Suppl 3:S18-26. Review.

PMID:
19409352
[PubMed - indexed for MEDLINE]
15.

Lessons from ONTARGET.

Berlaimont V, Billiouw JM, Brohet C, Dupont AG, Gazagnes MD, Heller F, Krzesinski JM, Missault L, Persu A, Piérard L, Rottiers R, Vanhooren G, Van Mieghem W, Vervaet P, Herman AG.

Acta Clin Belg. 2008 May-Jun;63(3):142-51. Review.

PMID:
18714845
[PubMed - indexed for MEDLINE]
16.

Clinical trial update: focus on the ONTARGET study.

Fitchett D.

Vasc Health Risk Manag. 2007;3(6):901-8. Review.

PMID:
18200809
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Renin-angiotensin system blockade and cardiovascular and renal protection.

Hoogwerf BJ.

Am J Cardiol. 2010 Jan 4;105(1 Suppl):30A-5A. doi: 10.1016/j.amjcard.2009.10.009. Review.

PMID:
20102971
[PubMed - indexed for MEDLINE]
18.

Comparative effects of telmisartan in the treatment of hypertension.

White WB.

J Clin Hypertens (Greenwich). 2002 Jul-Aug;4(4 Suppl 1):20-5. Review.

PMID:
12147925
[PubMed - indexed for MEDLINE]
19.

Angiotensin-converting enzyme inhibitors for stroke prevention: is there HOPE for PROGRESS After LIFE?

Hankey GJ; Heart Outcomes Prevention Evaluation; Perindopril Protection Against Recurrent Stroke Study; Losartan Intervention For Endpoint reduction in hypertension study.

Stroke. 2003 Feb;34(2):354-6. Review. No abstract available.

PMID:
12574534
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk